olivlawolivlaw

olivLaw · European equity research

Interparfums ITP.PA

France · Euronext Paris · ISIN FR0004024222 · Vertical: Listed companies from France

36.60EUR+3.39% · 1 dayClose 05 Nov 2026

Interparfums creates and develops fragrance lines for prestige brands, largely through licences from fashion, leather goods and jewellery houses, and also owns several brands outright. The company has limited exposure to Russia and is in a period of portfolio expansion, with launches planned for 2027 and 2028.

At the close of 05 Nov 2026, Interparfums (ITP.PA) stock was 36.60 EUR (+3.39% on the day), with market capitalisation 2.9 bn EUR, P/E 23.2 on diluted EPS of 1.58 EUR over the last 12 months, dividend yield 2.99%, beta 0.86, 52-week range 21.16–36.60 EUR.

Data as of · AI analysis dated · Source: ESEF annual reports and closing prices, computed by olivLaw.

Market cap
2.9 bn EUR
shares as of 31 Dec 2025
P/E (TTM)
23.2
Diluted EPS TTM 1.58 · TTM to 31 Dec 2025
E/P (TTM)
4.32%
TTM to 31 Dec 2025
Dividend yield
2.99%
DPS 12m 1.09
Beta (2y)
0.86
Volatility (1y) 32%
52-week range
21.1636.60

Price history

Loading chart…

Technical reading

RSI (14)
74.0
overbought (≥ 70)
Bollinger (20, 2)
30.31 – 36.77
in the upper half of the band · %B 0.97 · band width 19.2%
SMA 50 / 200
30.92 / 25.51
uptrend (price > SMA50 > SMA200)
MACD (12, 26, 9)
1.40 / 1.31
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyEURO STOXX 50vs EURO STOXX 50Vertical median
1 month+19.4%−0.6%+20.0 pp—
3 months+46.8%−4.2%+50.9 pp—
6 months+64.5%+4.3%+60.2 pp—
Year to date+52.4%+7.5%+44.9 pp—
1 year+37.9%+9.9%+28.0 pp−6.8%
3 years+3.6%+49.8%−46.3 pp−15.9%
5 years−22.2%+42.8%−65.0 pp—
Max drawdown (1y)
−19.8%
11 Nov 2025 → 15 May 2026
Max drawdown (5y)
−60.5%
21 Apr 2023 → 15 May 2026
Compound annual growth (5y)
−4.9%
EURO STOXX 50 +7.4%

Price returns, dividends excluded.

Quarterly results

ESEF annual reports carry no quarters: the results are annual (below).

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 67 percentile of its own 3-quarter history (min 15.2, median 20.8, max 23.2; quarters with earnings only).

Fiscal years

Fiscal year202320242025
Revenue798.5 m880.5 m899.4 m
Revenue YoYunavailable+10.3%+2.1%
Net income118.7 m129.9 m126.6 m
Net income YoYunavailable+9.4%−2.5%
Diluted EPS1.711.701.58
Diluted EPS YoYunavailable−0.6%−7.1%
net %14.9%14.7%14.1%
Free cash flow77.0 m105.0 m131.5 m

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
201.2 m EUR
Financial debt
96.1 m EUR
Net debt
-105.1 m EUR
Equity
731.7 m EUR
Total assets
1.0 bn EUR
Debt / equity
0.13x
Current ratio
2.95x
ROE
17.7%
ROA
12.2%
FCF margin
14.6%

Financial statements (source on every figure)

Revenue and net income (EUR)

Margins

Income statement · EUR

Revenue
2023
798.5 m
2024
880.5 m
2025
899.4 m

esef· 07 Apr 2026verified

Cost of revenue
2023
273.5 m
2024
302.7 m
2025
317.3 m

esef· 07 Apr 2026verified

Gross profit
2023
525.0 m
2024
577.8 m
2025
582.1 m

esef· 07 Apr 2026verified

Operating income
2023
165.6 m
2024
178.0 m
2025
175.2 m

esef· 07 Apr 2026verified

Interest expense
2023
7.4 m
2024
6.8 m
2025
5.8 m

esef· 07 Apr 2026verified

Pre-tax income
2023
163.3 m
2024
174.3 m
2025
166.0 m

esef· 07 Apr 2026verified

Income tax
2023
43.9 m
2024
44.4 m
2025
39.8 m

esef· 07 Apr 2026verified

Net income
2023
118.7 m
2024
129.9 m
2025
126.6 m

esef· 07 Apr 2026verified

Diluted EPS
2023
1.71
2024
1.70
2025
1.58

esef· 07 Apr 2026verified

Dividend per share
2023
0.95
2024
1.05
2025
1.09

esef· 07 Apr 2026derived

Balance sheet · EUR

Cash
2023
137.7 m
2024
183.1 m
2025
201.2 m

esef· 07 Apr 2026verified

Inventories
2023
202.4 m
2024
229.7 m
2025
197.2 m

esef· 07 Apr 2026verified

Current assets
2023
530.9 m
2024
596.4 m
2025
596.2 m

esef· 07 Apr 2026verified

Property, plant & equipment, net
2023
148.6 m
2024
143.8 m
2025
154.3 m

esef· 07 Apr 2026verified

Intangibles (excl. goodwill)
2023
—
2024
240.4 m
2025
251.4 m

esef· 07 Apr 2026verified

Total assets
2023
968.2 m
2024
1.0 bn
2025
1.0 bn

esef· 07 Apr 2026verified

Long-term debt
2023
98.7 m
2024
95.9 m
2025
96.1 m

esef· 07 Apr 2026verified

Current liabilities
2023
197.0 m
2024
216.3 m
2025
202.2 m

esef· 07 Apr 2026verified

Equity
2023
643.7 m
2024
698.6 m
2025
731.7 m

esef· 07 Apr 2026verified

Shares outstanding at year end
2023
69.4 m
2024
76.4 m
2025
80.1 m

esef· 07 Apr 2026derived

Cash flow · EUR

Operating cash flow
2023
84.5 m
2024
107.7 m
2025
150.0 m

esef· 07 Apr 2026verified

Capex
2023
7.5 m
2024
2.7 m
2025
18.5 m

esef· 07 Apr 2026verified

Free cash flow
2023
77.0 m ≈
2024
105.0 m ≈
2025
131.5 m ≈

esef· 07 Apr 2026derived

Investing cash flow
2023
34.0 m
2024
-18.2 m
2025
-41.6 m

esef· 07 Apr 2026verified

Financing cash flow
2023
-117.5 m
2024
-45.2 m
2025
-87.7 m

esef· 07 Apr 2026verified

Dividends paid
2023
65.9 m
2024
80.3 m
2025
87.6 m

esef· 07 Apr 2026verified

Computed indicators

Growth

Revenue growth (YoY)
2.1%
computed by olivLawFY 2025
Revenue CAGR 3Y
unavailable
input data missing
Revenue CAGR 5Y
unavailable
input data missing
EBIT growth (YoY)
-1.6%
computed by olivLawFY 2025
Net income growth (YoY)
-2.5%
computed by olivLawFY 2025
Net income CAGR 3Y
unavailable
input data missing
Net income CAGR 5Y
unavailable
input data missing
EPS growth (YoY)
-7.1%
computed by olivLawFY 2025
EPS CAGR 3Y
unavailable
input data missing
EPS CAGR 5Y
unavailable
input data missing
FCF growth (YoY)
25.2%
computed by olivLawFY 2025

Profitability

Gross margin
64.7%
computed by olivLawFY 2025
EBITDA margin
unavailable
input data missing
EBIT margin
19.5%
computed by olivLawFY 2025
Net margin
14.1%
computed by olivLawFY 2025
FCF margin
14.6%
computed by olivLawFY 2025

Returns

ROE
17.7%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROA
12.2%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROIC
21.5%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROCE
20.7%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Payout ratio (EPS)
69.2%
computed by olivLawFY 2025
Payout ratio (FCF)
66.6%
computed by olivLawFY 2025

Balance sheet

Net debt
-105.1 m EUR
computed by olivLawbalance sheet at 31 Dec 2025
Net debt / EBITDA
unavailable
input data missing
Debt / equity
0.1x
computed by olivLawbalance sheet at 31 Dec 2025
Interest coverage
30.2x
computed by olivLawFY 2025

Liquidity

Current ratio
2.9x
computed by olivLawbalance sheet at 31 Dec 2025
Quick ratio
2.0x
computed by olivLawbalance sheet at 31 Dec 2025
Cash ratio
1.0x
computed by olivLawbalance sheet at 31 Dec 2025

Cash

Operating cash flow
150.0 m EUR
computed by olivLawFY 2025
Capital expenditure
18.5 m EUR
computed by olivLawFY 2025
Free cash flow
131.5 m EUR
computed by olivLawFY 2025
FCF conversion
103.9%
computed by olivLawFY 2025
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
unavailable
input data missing
Days inventory outstanding
246 days
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Days payables outstanding
unavailable
input data missing
Cash conversion cycle
unavailable
input data missing

Market and valuation

Market capitalisation
2.9 bn EUR
computed by olivLawbalance sheet at 31 Dec 2025
Enterprise value
2.8 bn EUR
computed by olivLawbalance sheet at 31 Dec 2025
Market cap / net income TTM
23.2x
computed by olivLawFY 2025
P/E (TTM)
23.2x
computed by olivLawFY 2025
Earnings yield
4.3%
computed by olivLawFY 2025
P/B
4.0x
computed by olivLawbalance sheet at 31 Dec 2025
P/S
3.3x
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
EV/EBITDA
unavailable
input data missing
EV/EBIT
16.1x
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
EV/Sales
3.1x
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
P/FCF
22.3x
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
FCF yield
4.5%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Dividend yield
3.0%
computed by olivLawFY 2025
Shareholder yield (distributions)
3.0%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Unattractive profile

Score: 74 / 100

A scoring methodology on indicators and valuation, not investment advice.

(margin_of_safety <= -0.25 & agreement in ['high', 'medium'])

Closing price

36.60 EUR

05 Nov 2026Source: olivLaw, closing series

Market cap: 2.9 bn EUR

Key indicators

Market capitalisation
2.9 bn EUR
computed by olivLawbalance sheet at 31 Dec 2025
P/E (TTM)
23.2x
computed by olivLawFY 2025
P/B
4.0x
computed by olivLawbalance sheet at 31 Dec 2025
EV/EBITDA
unavailable
input data missing
ROE
17.7%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Net margin
14.1%
computed by olivLawFY 2025
Revenue growth (YoY)
2.1%
computed by olivLawFY 2025
Dividend yield
3.0%
computed by olivLawFY 2025

Coverage and freshness

26/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 31 Dec 2025
Latest balance sheet date: 31 Dec 2025
Share count (cover of the latest filing), as of: 31 Dec 2025
Source: esefpublished 07 Apr 2026
verified 78derived 6

Score by group

  • Valuation49
  • Balance sheet100
  • Returns56
  • Quality90

Estimated value range

Low
17.52
EUR per share
Mid
27.07
EUR per share
High
36.48
EUR per share
Price: 36.60 EUR
The price is above the range
Potential to the central value: -26.0% (value / price − 1)
Margin of safety: -35.2% (1 − price / value)
Agreement between methods: medium · 3 methods used · 3 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 14.88 – 47.09 EUR.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (EUR per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)23.79 – 36.48 (Mid 28.65)
    WACC 8.4% · starting FCFF 135.9 m EUR · terminal value share of EV 74%
    The WACC × g sensitivity gives the method's bounds; these are not probabilities.
    Reverse DCF: starting growth implied by the price (fading linearly to terminal growth, everything else fixed): 13.6%
  • Peers: EV/EBITDAunavailable · input data missing
  • Peers: P/E17.52 – 47.09 (Mid 27.07)
    20 companies used · median multiple 17.1x · quartiles 11.1x – 29.8x
    74SW.PA, ABEO.PA, AC.PA, ADP.PA, AF.PA, AI.PA, ALBON.PA, ALCIS.PA, ALCLA.PA, ALFER.PA, ALHEX.PA, ALO.PA, ALPWG.PA, ALSOG.PA, ANTIN.PA, ARAMI.PA, ATE.PA, AUB.PA, AURE.PA, BB.PA
  • Dividend discount (DDM)14.88 – 20.29 (Mid 17.16)

Assumptions (illustrative, editorial)

Risk-free rate
3.0%
Equity risk premium
5.5%
Beta (default)
1.00
Cost of equity
8.5%
Terminal growth
2.0%

Factor scorecard

Unattractive profile · Score 74/100

FactorValueScoreWeight used
ROIC · Quality21.5%81 (vs peers)17%
Net margin · Quality14.1%95 (vs peers)10%
FCF conversion · Quality103.9%100 (on a fixed band)10%
Revenue CAGR 3Y · Growthunavailableunavailable—
EPS CAGR 3Y · Growthunavailableunavailable—
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheet30.2x100 (on a fixed band)10%
Current ratio · Balance sheet2.9x100 (on a fixed band)7%
P/E (TTM) · Valuation23.2x43 (vs peers)17%
EV/EBITDA · Valuationunavailableunavailable—
FCF yield · Valuation4.5%56 (on a fixed band)13%
Shareholder yield (distributions) · Returns3.0%43 (on a fixed band)10%
Payout ratio (FCF) · Returns66.6%76 (on a fixed band)7%

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet100/100 · 2/3 factors with a value
  • Growth· partialunavailable · 0/2 factors with a value
  • Quality90/100 · 3/3 factors with a value
  • Returns56/100 · 2/2 factors with a value
  • Valuation49/100 · 2/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

INTERPARFUMS (ITP.PA). Latest full fiscal year: 2025; data up to 2025-12-31.

Figures computed from the financial statements: revenue 899.4 m EUR in 2025; YoY growth 2.1%; net margin 14.1%; ROE 17.7%.

The estimated value range is 17.52–36.48 EUR per share (median of 3 methods, agreement: medium); assumptions are illustrative. Against the central value of 27.07 EUR, the price of 36.60 EUR leaves a potential of -26.0% (value / price − 1) and a margin of safety of -35.2% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

olivLaw score 74/100, methodological classification: unattractive profile (score, margin of safety and method agreement together; not a judgement of the right price). Groups assessed only in part: growth. Not investment advice.

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • ROIC: 21.5%
  • Net margin: 14.1%
  • FCF conversion: 103.9%
  • Interest coverage: 30.2x
  • Current ratio: 2.9x
  • Payout ratio (FCF): 66.6%

What contradicts it

  • The price is above the estimated value range

Not assessed (insufficient data or a ratio without meaning): Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, EV/EBITDA.

Versus the vertical median

Listed companies from France · same country · compared with 39 companies

Multiples and returns vs the median

P/E
23.2x
vertical median 18.3x
above median (+26.8%)
EV/EBITDA
—
vertical median 6.3x
P/S
3.3x
vertical median 0.5x
above median (+536.9%)
P/B
4.0x
vertical median 1.1x
above median (+280.5%)
ROE
17.7%
vertical median 4.2%
above median (+327.0%)
Net margin
14.1%
vertical median 1.1%
above median (+1,148.7%)
EBIT margin
19.5%
vertical median 3.2%
above median (+513.5%)
Revenue YoY
2.1%
vertical median 0.6%
above median (+264.5%)
Net debt/EBITDA
—
vertical median -1.2x
Dividend yield
3.0%
vertical median 1.7%
above median (+75.6%)

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
AI.PAL'air Liquide Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude109.3 bn33.212.9%12.2%−2.0%+26% / +32%
AC.PAAccor13.8 bn30.79.6%8.0%+0.6%+6% / +56%
ADP.PAAeroports De Paris11.7 bn34.17.8%5.6%+12.1%−7% / +4%
AKE.PAArkema7.1 bn115.40.9%0.7%−5.0%+12% / −37%
ALO.PAAlstom5.8 bn18.33.1%1.7%+3.7%−51% / −4%
AF.PAAir France - Klm4.3 bn13.6—1.0%+4.8%+20% / +9%
ATE.PAAlten3.1 bn29.54.8%2.6%−1.1%+33% / −29%
ITP.PAInterparfums2.9 bn23.217.7%14.1%+2.1%+57% / −6%
BB.PASociete Bic2.7 bn31.35.0%4.1%−4.8%+32% / +5%
ANTIN.PAAntin Infrastructure Partners1.4 bn13.021.9%36.6%−8.1%−24% / −35%
74SW.PA74software792.7 m20.98.9%8.5%+44.8%−13% / +41%
AUB.PAAubay667.4 m17.813.6%6.3%+11.3%+3% / +45%
ASY.PAAssystem507.1 m69.92.5%1.1%+7.4%−19% / −18%
ATO.PAAtos Se483.0 m—-23,400.0%-17.5%−16.5%−45% / −94%
ARAMI.PAAramis Group298.8 m15.010.0%0.8%+6.3%−33% / −16%
ARVEN.PAArverne Group246.1 m—-14.0%-115.3%+27.0%+20% / −35%
BGO.PACompagnie Chargeurs Invest189.4 m—-8.6%-5.7%−2.9%unavailable / unavailable
ALCIS.PACatering International & Services145.0 m28.49.3%1.9%+5.8%+39% / +107%
ALCGM.PACegedim144.6 m—-2.6%-1.2%+10.9%−26% / −49%
ATEME.PAAteme144.0 m151.32.8%1.0%+2.2%+82% / +77%
ALHEX.PAHexaom144.0 m6.79.9%2.2%+13.1%−32% / +7%
ALBON.PACompagnie Lebon111.7 m16.54.2%8.8%−17.9%+6% / +8%
ALHYF.PALhyfe75.8 m—-33.4%-570.5%+287.2%unavailable / unavailable
ALFER.PASergeferrari Group61.5 m11.55.1%1.5%+7.4%−33% / −27%
ABEO.PAAbeo60.8 m7.36.9%3.0%+12.6%−13% / −54%

1- and 3-year price returns: for ITP.PA from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (EUR)

Estimated priceBearBaseBull
1 years
21.12
Total return -40% · Per year -40%
37.39
Total return 5% · Per year 5%
56.37
Total return 58% · Per year 58%
3 years
19.54
Total return -40% · Per year -16%
39.01
Total return 16% · Per year 5%
64.72
Total return 89% · Per year 24%
5 years
18.08
Total return -40% · Per year -10%
40.70
Total return 27% · Per year 5%
74.29
Total return 124% · Per year 18%
What moves the 3-year price the most
  • Exit P/E± 9.75
  • Net margin± 6.83
  • Annual revenue growth± 5.73
  • Annual dilution± 0.57

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

Interparfums creates and develops fragrance lines for prestige brands, largely through licences from fashion, leather goods and jewellery houses, and also owns several brands outright. The company has limited exposure to Russia and is in a period of portfolio expansion, with launches planned for 2027 and 2028 1.

SWOT

Strengths

  • Diversified portfolio of prestige brands, a solid balance sheet and founder control that allow long-term planning.
  • Model without owned production sites, with trusted industrial partners and sourcing concentrated in Western Europe.
  • The mix of licences and owned brands reduces dependence on any single brand.

Weaknesses

  • Dependence on licence contracts, with the risk that an important licensor does not renew its agreement.
  • Revenue concentrated in a few large brands makes results sensitive to their performance.
  • Market share remains modest compared with the largest players, which limits bargaining power.

Opportunities

  • Launches planned for 2027 and 2028 on recently acquired or signed brands could open new revenue sources.
  • Extending existing partnerships, such as the one with Boucheron, could strengthen revenue over the medium term.
  • Affordable and artisanal niche segments leave room for portfolios different from the traditional model.

Threats

  • Changes in US import tariffs could raise the cost of imports for the American subsidiary.
  • Geopolitical instability in some export regions could affect collections and demand.
  • Stricter rules on ingredients may force costly reformulations.

Risks

  • Non-renewal of a major licencehigh

    If an important licence contract is not renewed, revenue and profitability could be affected, although the long contract terms and owned brands limit the impact.

  • US tariffsmedium

    Changes in US trade policy can alter the import costs of the American subsidiary, and the framework remains uncertain.

  • Geopolitical exposuremedium

    Sales to Russia, Belarus and Ukraine are limited, but tensions in some regions could affect collections from distributors.

  • Impairment of intangible assetsmedium

    Many assets are brands and licence entry rights whose value depends on future results; a change in assumptions could lead to impairment.

  • Brand reputationlow

    An incident affecting the image of a licensor or of the group could influence sales and relations with partners.

Investment thesis

What would need to be true (bull case)

  • The prestige brand portfolio and the launches planned for the coming period could support growth if well received by consumers.
  • The solid balance sheet and founder control allow investment and brand acquisitions without excessive financing pressure.
  • Limited exposure to high-risk markets and a model without owned factories could reduce fixed costs and operating risks.

What would break the thesis

  • Dependence on licences and a few large brands means a single event could have a significant impact on results.
  • US tariffs and regulations could raise costs in a market that is very important for the group.
  • Competition from large groups with much bigger marketing budgets may limit gains in market share.

What to watch

  • Performance of the roughly 15 planned fragrance line extensions2026
  • First projects on Annick Goutal, Off-White and Longchamp2027
  • Effect of US tariffs on the American subsidiarynext 10-K
  • Outcome of the shareholder vote on the new share buyback programme2026

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

Interparfums is a specialist in creating, developing and distributing prestige fragrances, with a portfolio of 15 brands, most of them under licence 1. The group owns no production sites and works with a network of industrial partners, with 88 % of sourcing coming from Western Europe 1. The company is listed on Euronext Paris, is controlled by its founders and reports a solid balance sheet with net cash after debt of 63 M EUR 1.

Segments

Licensed brands

Most of the activity rests on licences from fashion, leather goods and jewellery houses, for which Interparfums pays royalties indexed to sales. Contracts run for ten years or more, which limits non-renewal risk 1.

Owned brands

The group owns in its own name brands such as Lanvin and Rochas for fragrances, Off-White for fragrances and cosmetics, and acquired Annick Goutal in 2025. The Solférino brand, launched in 2025 with a Paris boutique, adds to this direction 1.

Market context

The global selective fragrance market is estimated at around 40 bn USD, according to an internal company source 1. Interparfums holds a share of about 4 % in prestige selective distribution in France and between 2 % and 5 % in several foreign markets, including the United States and China 1.

The market is polarised between accessibility, through dupes, and ultra-exclusivity, through Haute Parfumerie, and consumers can pick both directions at the same time 1.

Trends

  • Market polarisationmixed

    Demand splits between affordable products and artisanal niche fragrances, which can open room for diversified portfolios but also requires clear positioning.

  • Sustainability and traceabilitytailwind

    Consumers ask for transparency on ingredients and packaging, which could favour suppliers and brands that already run traceability systems.

  • Tighter regulationheadwind

    Updates on allergens and toxicological profiles can require reformulations, which could raise technical costs and delay launches.

  • Inclusive and personalised fragrancetailwind

    Genderless and customised fragrances are increasingly sought after, which can support more launches and line extensions.

Competitive position

The sector is dominated by a few large historical players with fragrance divisions in the billions of euros, and Interparfums belongs to a group of mid-sized players. Its model focuses on creating and retaining consumers rather than on volume and heavy advertising 1.

Competitors cited by the company include L'Oréal, Coty, Shiseido, Estée Lauder, LVMH, Chanel and Puig, some operating mainly under licences and others mainly with owned brands 1.

  • L'Oréal

    Large cosmetics group with a fragrance division, cited by the company as a main player in the sector.

  • CotyCOTY

    Major fragrance player with licensed brands, named in the competitive analysis.

  • Estée LauderEL

    US cosmetics group with a strong prestige fragrance division.

  • LVMH

    Luxury group with its own fragrance houses, cited among the major companies in the sector.

News & filings

Annual reports (ESEF)

Sources

  1. [1] Annual report, fiscal year ended 2025-12-31 (ESEF) · SEC / Interparfums · 31 Dec 2025

Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.